BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17690949)

  • 1. Brivaracetam is superior to levetiracetam in a rat model of post-hypoxic myoclonus.
    Tai KK; Truong DD
    J Neural Transm (Vienna); 2007; 114(12):1547-51. PubMed ID: 17690949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
    Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
    Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
    Genton P; Gelisse P
    Neurology; 2001 Sep; 57(6):1144-5. PubMed ID: 11571362
    [No Abstract]   [Full Text] [Related]  

  • 4. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
    Frucht SJ; Louis ED; Chuang C; Fahn S
    Neurology; 2001 Sep; 57(6):1112-4. PubMed ID: 11571347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapolation of a Brivaracetam Exposure-Response Model from Adults to Children with Focal Seizures.
    Schoemaker R; Wade JR; Stockis A
    Clin Pharmacokinet; 2018 Jul; 57(7):843-854. PubMed ID: 28884437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Effects of Time-Limited Treatment with Brivaracetam on Posttraumatic Epilepsy after Fluid Percussion Injury in the Rat.
    Eastman CL; Fender JS; Klein P; D'Ambrosio R
    J Pharmacol Exp Ther; 2021 Dec; 379(3):310-323. PubMed ID: 34593559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimyoclonic effect of levetiracetam.
    Genton P; Gélisse P
    Epileptic Disord; 2000 Dec; 2(4):209-12. PubMed ID: 11174151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dramatic effect of levetiracetam on epileptic negative myoclonus.
    Gelisse P; Crespel A; Genton P; Baldy-Moulinier M
    Acta Neurol Scand; 2003 Apr; 107(4):302-3. PubMed ID: 12675706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison.
    Zhang L; Li S; Li H; Zou X
    Seizure; 2016 Jul; 39():28-33. PubMed ID: 27236448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel rat cardiac arrest model of posthypoxic myoclonus.
    Truong DD; Matsumoto RR; Schwartz PH; Hussong MJ; Wasterlain CG
    Mov Disord; 1994 Mar; 9(2):201-6. PubMed ID: 8196684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: relationship to anti-convulsant properties.
    Gillard M; Fuks B; Leclercq K; Matagne A
    Eur J Pharmacol; 2011 Aug; 664(1-3):36-44. PubMed ID: 21575627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?
    Swallow E; Fang A; Signorovitch J; Plumb J; Borghs S
    CNS Drugs; 2017 Oct; 31(10):899-910. PubMed ID: 28856580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam-associated aggravation of myoclonic seizure in children.
    Liu YH; Wang XL; Deng YC; Zhao G
    Seizure; 2012 Dec; 21(10):807-9. PubMed ID: 22990039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levetiracetam use in the post-hypoxic myoclonic status].
    Cáceres-Agra JJ; Santana-Cabrera L; Fernández-Arroyo M; Sánchez-Palacios M
    Med Clin (Barc); 2009 Mar; 132(9):369. PubMed ID: 19230933
    [No Abstract]   [Full Text] [Related]  

  • 15. [Brivaracetam for add-on treatment in focal epilepsy].
    Strzelczyk A; Steinig I; Klein KM; Willems LM; Knake S; Rosenow F; Bauer S
    Nervenarzt; 2016 Oct; 87(10):1086-1093. PubMed ID: 27389600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketogenic diet prevents seizure and reduces myoclonic jerks in rats with cardiac arrest-induced cerebral hypoxia.
    Tai KK; Truong DD
    Neurosci Lett; 2007 Sep; 425(1):34-8. PubMed ID: 17825488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of disabling myoclonus in a case of DRPLA by levetiracetam.
    Kobayashi K; Takeuchi A; Oka M; Akiyama M; Ohtsuka Y
    Brain Dev; 2012 May; 34(5):368-71. PubMed ID: 21889282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gaucher disease: successful treatment of myoclonic status epilepticus with levetiracetam.
    Vaca GF; Lenz T; Knight EM; Tuxhorn I
    Epileptic Disord; 2012 Jun; 14(2):155-8. PubMed ID: 22569507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study.
    Lowrie M; Thomson S; Bessant C; Sparkes A; Harvey RJ; Garosi L
    J Feline Med Surg; 2017 Feb; 19(2):200-206. PubMed ID: 26690830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus.
    Strzelczyk A; Klein KM; Willems LM; Rosenow F; Bauer S
    Expert Rev Clin Pharmacol; 2016; 9(5):637-45. PubMed ID: 26891946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.